• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺失的锌:p53 错误折叠与癌症。

The missing zinc: p53 misfolding and cancer.

机构信息

Department of Biochemistry & Molecular Biology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA.

出版信息

Metallomics. 2010 Jul;2(7):442-9. doi: 10.1039/c003915b. Epub 2010 May 18.

DOI:10.1039/c003915b
PMID:21072344
Abstract

The p53 tumor suppressor is a transcription factor that contains a single zinc ion near its DNA binding interface. Zn(2+) is required for site-specific DNA binding and proper transcriptional activation. In addition to its functional significance, zinc plays a dominant role in determining whether p53 folds productively or misfolds. Insufficient zinc and excess zinc cause p53 to misfold by distinct mechanisms which both result in functional loss. The zinc-binding status of p53 in the cell is impacted significantly by the presence of tumorigenic mutations and by metal ion homeostasis. This review discusses mechanisms by which zinc modulates folding and misfolding of p53, how improper metal binding and release leads to loss of function and cancer, and how misfolding can be rescued by metallochaperones.

摘要

抑癌基因 p53 是一种转录因子,其 DNA 结合界面附近含有一个锌离子。Zn(2+) 对于特定的 DNA 结合和适当的转录激活是必需的。除了其功能意义之外,锌在决定 p53 是否折叠正确或错误方面起着主导作用。锌不足和锌过量通过不同的机制导致 p53 错误折叠,这两种机制都会导致功能丧失。肿瘤发生突变和金属离子稳态对细胞中 p53 的锌结合状态有显著影响。这篇综述讨论了锌如何调节 p53 的折叠和错误折叠,以及不当的金属结合和释放如何导致功能丧失和癌症,以及金属伴侣蛋白如何拯救错误折叠。

相似文献

1
The missing zinc: p53 misfolding and cancer.缺失的锌:p53 错误折叠与癌症。
Metallomics. 2010 Jul;2(7):442-9. doi: 10.1039/c003915b. Epub 2010 May 18.
2
Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.p53 DNA 结合结构域无锌形式的结构、功能及聚集情况
Biochemistry. 2003 Mar 4;42(8):2396-403. doi: 10.1021/bi026635n.
3
Zn(2+)-dependent misfolding of the p53 DNA binding domain.锌离子(Zn²⁺)依赖的p53 DNA结合结构域错误折叠
Biochemistry. 2007 Mar 13;46(10):2630-9. doi: 10.1021/bi062106y. Epub 2007 Feb 13.
4
Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function.四聚体 p53 的折叠:寡聚化和致瘤突变诱导错误折叠和功能丧失。
J Mol Biol. 2010 Jan 29;395(4):705-16. doi: 10.1016/j.jmb.2009.11.013. Epub 2009 Nov 11.
5
Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.通过调节金属硫蛋白和锌来恢复HIPK2缺失的MCF7细胞中的野生型p53活性。
Exp Cell Res. 2009 Jan 1;315(1):67-75. doi: 10.1016/j.yexcr.2008.10.018. Epub 2008 Oct 28.
6
The effect of zinc and the role of p53 in copper-induced cellular stress responses.锌的作用及 p53 在铜诱导的细胞应激反应中的作用。
J Appl Toxicol. 2013 Jul;33(7):527-36. doi: 10.1002/jat.2854. Epub 2013 Feb 11.
7
Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer.利用小分子作为锌金属伴侣激活突变型p53:唤醒癌症中的沉睡巨头。
Drug Discov Today. 2015 Nov;20(11):1391-7. doi: 10.1016/j.drudis.2015.07.006. Epub 2015 Jul 20.
8
Effect of metal ion on the structural stability of tumour suppressor protein p53 DNA-binding domain.金属离子对肿瘤抑制蛋白p53 DNA结合结构域结构稳定性的影响。
J Biochem. 2009 Aug;146(2):193-200. doi: 10.1093/jb/mvp055. Epub 2009 Apr 3.
9
Folding and misfolding mechanisms of the p53 DNA binding domain at physiological temperature.生理温度下p53 DNA结合结构域的折叠与错误折叠机制
Protein Sci. 2006 Nov;15(11):2457-65. doi: 10.1110/ps.062324206. Epub 2006 Sep 25.
10
Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.抑制性突变恢复突变型p53序列特异性DNA结合及反式激活作用的结构基础
J Mol Biol. 2009 Jan 9;385(1):249-65. doi: 10.1016/j.jmb.2008.10.063. Epub 2008 Oct 30.

引用本文的文献

1
Nanopore sensing of protein and peptide conformation for point-of-care applications.用于即时检测应用的蛋白质和肽构象的纳米孔传感
Nat Commun. 2025 Apr 4;16(1):3211. doi: 10.1038/s41467-025-58509-8.
2
Deciphering the safeguarding role of cysteine residues in p53 against HO-induced oxidation using high-resolution native mass spectrometry.利用高分辨率天然质谱解析半胱氨酸残基在p53中对羟基诱导氧化的保护作用。
Commun Chem. 2025 Jan 15;8(1):13. doi: 10.1038/s42004-024-01395-w.
3
TRPM channels in human cancers: regulatory mechanism and therapeutic prospects.
人类癌症中的瞬时受体电位阳离子通道(TRPM):调控机制与治疗前景
Biomark Res. 2024 Dec 4;12(1):152. doi: 10.1186/s40364-024-00699-2.
4
Bioinformatic Characterization of the Functional and Structural Effect of Single Nucleotide Mutations in Patients with High-Grade Glioma.高级别胶质瘤患者单核苷酸突变功能和结构效应的生物信息学特征分析
Biomedicines. 2024 Oct 9;12(10):2287. doi: 10.3390/biomedicines12102287.
5
Selenium, Zinc, and Plasma Total Antioxidant Status and the Risk of Colorectal Adenoma and Cancer.硒、锌与血浆总抗氧化状态及结直肠腺瘤和癌症风险
Metabolites. 2024 Sep 6;14(9):486. doi: 10.3390/metabo14090486.
6
Anticancer therapeutic strategies for targeting mutant p53-Y220C.靶向突变型p53-Y220C的抗癌治疗策略。
J Biomed Res. 2024 May 13;38(3):222-232. doi: 10.7555/JBR.37.20230093.
7
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
8
Dietary intake and serum levels of copper and zinc and risk of hepatocellular carcinoma: A matched case-control study.膳食铜和锌摄入量、血清水平与肝细胞癌风险:一项配对病例对照研究。
Chin Med J (Engl). 2024 Mar 5;137(5):596-603. doi: 10.1097/CM9.0000000000002761. Epub 2023 Nov 28.
9
Effects of Copper or Zinc Organometallics on Cytotoxicity, DNA Damage and Epigenetic Changes in the HC-04 Human Liver Cell Line.铜或锌有机金属化合物对 HC-04 人肝癌细胞系细胞毒性、DNA 损伤和表观遗传变化的影响。
Int J Mol Sci. 2023 Oct 25;24(21):15580. doi: 10.3390/ijms242115580.
10
The Development of p53-Targeted Therapies for Human Cancers.用于人类癌症的p53靶向疗法的发展
Cancers (Basel). 2023 Jul 10;15(14):3560. doi: 10.3390/cancers15143560.